Abstract
The aging of the world population and the development of degenerative diseases, such as Parkinson's and Alzheimer's, whose cures are still unknown, have required creating strategies that make it possible to study them. The development of new drugs to prevent and treat these diseases depends on drug delivery strategies that can cross the Blood-Brain Barrier (BBB). The BBB, composed of endo…